Coiante Scott M
SEC CIK 1608536 · EDGAR
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
| 13 | Coiante Scott M | SVP, CFO | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Coiante Scott M | SVP, CFO | M - OptEx | — | +160.2K | 160.2K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Coiante Scott M | SVP, CFO | F - Tax | $1.47 | -54.9K | 105.4K | -34% | -$80.7K |
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, CFO | A - Grant | $0.00 | +60.8K | 145.1K | +72% | $0 |
| 2022-06-07 | 2022-06-03 | APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, CFO, Dir | F - Tax | $0.81 | -35.3K | 84.3K | -30% | -$28.6K | |
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, CFO, Dir | A - Grant | $0.00 | +42.9K | 119.5K | +56% | $0 |
| 2022-03-01 | 2022-02-25 | APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, CFO | F - Tax | $1.74 | -14.8K | 76.6K | -16% | -$25.8K | |
| 2021-08-27 | 2021-08-25 | APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, CFO | F - Tax | $3.98 | -7,534 | 91.5K | -8% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations